Start exploring your own markets for free

🚀 Try for Free

AI Therapeutics

Light Search completed

Invite

Radar Tracking

Subspaces (4)

Drug Discovery Optimization

Biomarker Identification

Genomic Data Analysis

Drug Repurposing

Pending to review

Not sure yet

Interested

Not interested

Download list

Showing 104 results

Company	Fit assessment	Description	Subspaces	Tags	HQ Location	Founding Date	Employees	Total Funding Raised	Last Funding Event	Received on
RECEPTOR.AI	Receptor.AI leverages machine learning and AI technologies to discover new drug candidates and expand therapeutics, optimizing the drug discovery process.	Developer of AI-powered drug discovery platform designed to identify novel targets and design drug candidates with high success rates in clinical trials. The company is focused on providing an AI-driven drug discovery platform for pharma, biotech, and academia that covers the whole drug discovery pipeline in a flexible and scalable manner, thereby enabling an increase in precision of drug candidate design and the quality of their assessment and target specificity.	Drug Discovery Optimization	Light Search	London (United Kingdom)	2021	11 - 50	$500.00K	Grant, December 1, 2022	Oct 14, 2024
Pepticom	Pepticom leverages machine learning to discover innovative peptide therapeutics, optimizing the drug discovery process and expanding therapeutic options.	Developer of a biotechnology company intended to streamline the drug discovery process using artificial intelligence. The company's platform offers technology that decreases the cost and time of drug discovery and improves current treatments for today's many unaddressed diseases, addresses the problem of inefficiency around the design and discovery of therapeutics, enabling healthcare professionals with cell permeability, and an infinite chemical space that provides significant advantages over other therapeutic modalities.	Drug Discovery Optimization	Light Search	Israel	2011	11 - 50	$7.60M	Venture - Series Unknown, $2.60M, March 9, 2021	Oct 14, 2024
Genix.AI	Genix.ai effectively leverages machine learning for clinical investigations, discovering patterns in genomic data, and expanding therapeutic strategies for personalized medicine.	Developer of a genomic medicine platform designed to leverages machine learning to analyse genetic data and medical imaging for personalized treatment plans. The company's platform offers advanced clinical analysis using machine learning-powered pipelines to interpret genetic data and medical images, enabling customers to gain deeper insights into diseases, identify effective treatment options.	Genomic Data Analysis	Light Search	India	2021	1 - 10		NA	Oct 14, 2024
Delta4	Delta 4 effectively utilizes machine learning for drug discovery, identifies new patterns in drug-disease relationships, and expands therapeutic options through drug repurposing.	Operator of a digital drug discovery and development company intended to drive the forefront of digital drug discovery and development. The company's platform leverages a proprietary computational analytics platform, combined with straightforward biomedical testing and clinical validation of candidate drugs, and integrates iterative big data with an artificial intelligence-based in-silico platform and experimental screens, enabling researchers to discover treatments for the most complex and rare diseases and offer them efficient matching of clinical indications and compound/drug effect.	Drug Repurposing Drug Discovery Optimization	Light Search	Austria	2019	1 - 10		Series A, April 7, 2021	Oct 14, 2024
OutSee	OutSee leverages machine learning for genomic data analysis, discovering patterns and expanding therapeutic approaches in drug development.	Developer of an AI genomics technology designed to analyze genetic data for novel discoveries in drug development and precision medicine. The company's technology helps in standard analysis methods to identify potential causal mechanisms in diseases, approaches to identify causes of disease and inform drug discovery efforts, even with datasets previously analyzed by other methods, enabling researchers to get additional insights from existing genetic datasets.	Genomic Data Analysis	Light Search	United Kingdom	2022	1 - 10		NA	Oct 14, 2024
10x Genomics (NAS: TXG)	10x Genomics develops advanced DNA sequencing technology and innovative tools for analyzing biological systems, enabling researchers to uncover complex cellular interactions and gene expression patterns in various fields, including oncology and immunology. Their product portfolio includes instruments, consumables, and software designed to enhance scientific discovery.	10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.	Genomic Data Analysis	Light Search	United States	2012	1001 - 5000	$3.90B	Post-IPO Equity, January 1, 2020	Oct 14, 2024
AIA Insights Ltd	AIA Insights leverages machine learning and AI algorithms in its Drug Engine platform to enhance drug discovery, identify new therapeutic candidates, and streamline the research process.		Drug Discovery Optimization	Light Search	London (United Kingdom)		1 - 10		NA	Oct 14, 2024
NonExomics	NonExomics leverages machine learning to discover new patterns in genomic data and expand therapeutics for rare diseases.	Operator of a healthcare-based data analytics company intended to diagnose and cure diseases. The company's platform integrates genomics, transcriptomic, and proteomics data by utilizing proprietary machine-learning approaches to predict structures of noneconomic proteins and identify and prioritize disease-specific noneconomic targets, enabling researchers to find cures for rare diseases.	Genomic Data Analysis	Light Search	United States	2021	1 - 10	$200.00K	Non-Equity Assistance, March 16, 2022	Oct 14, 2024
OpenDNA	OpenDNA effectively leverages machine learning for genomic data analysis, enabling personalized treatment strategies and discovering new patterns in genetic risks.	Operator of a biotechnology company intended to offer genetically personalized medicine for chronic multi-gene diseases. The company's platform uses precision genomic AI that combines clinical and genomic data for detailed analysis of heart diseases and its prediction models help identify high-risk patients and their key prevention strategies, enabling physicians to easily prescribe the genetically fit treatment to their patients at a point of care.	Genomic Data Analysis	Light Search	Israel	2018	1 - 10		NA	Oct 14, 2024
Pinnacle	Pinnacle leverages machine learning and genomic AI to discover patterns and expand therapeutics, making it a strong fit for the specified requirements.	Operator of a global healthcare technology firm intended to provide genomics, healthcare, insurance, and life science solutions. The company offers primary data analysis tools, quantum computing, cloud storage, biological interpretation, and reporting tools combined to create actionable assets for biotechnology enterprises and partners with diagnostic labs and biopharma to leverage the SaaS platform to extract complex biomedical data, thereby helping clients improve health outcomes, drive innovation, and enhance efficiencies and business agility.	Genomic Data Analysis	Light Search	United States	2001	1001 - 5000		NA	Oct 14, 2024